MetaVia Inc. (MTVA)
NASDAQ: MTVAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
MTVA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $9.62M
- EPS (TTM)
- -$3.65
- Dividend yield
- None
- 52-week range
- 0.966 – 14.85
- Day range
- 1.46 – 1.52
- Volume / Avg
- 30.81K / 234.05K
- Beta
- —
- Shares outstanding
- 6.59M
- Next earnings
- Nov 5, 2026
52-week range
MTVA stock today
On Oct 7, MTVA ended the session at $1.46, shedding $0.02 (1.35%), versus the S&P 500's 0.22% decline. Trading was light, with 30.81K shares changing hands, about 13% of the average daily volume. At this level, MTVA sits near the bottom of its 52-week range of $0.966 to $14.85: 90.2% below the high and 51.1% above the low.
MetaVia has posted a net loss over the last twelve months (EPS of -$3.65), so its P/E ratio is not meaningful. MetaVia's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About MetaVia
Company profile- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- IPO year
- 2016
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.94
MetaVia peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| JAGXJaguar Health Inc. | 5.00 | -11.03% | $9.73M | vs MTVA |
| CMMBChemomab Therapeutics Ltd. ADR | 1.37 | -2.14% | $10.04M | vs MTVA |
| CALCCalciMedica Inc. | 1.48 | 0.00% | $10.11M | vs MTVA |
| ADILAdial Pharmaceuticals Inc | 3.99 | +0.25% | $10.48M | vs MTVA |
| MBRXMoleculin Biotech Inc. | 0.4389 | -1.48% | $8.95M | vs MTVA |
| APUSApimeds Pharmaceuticals US Inc. | 7.05 | -1.12% | $10.64M | vs MTVA |
| IMRNImmuron Limited ADR | 1.09 | +1.40% | $8.80M | vs MTVA |
| TOVXTheriva Biologics Inc. | 0.234 | +5.41% | $10.74M | vs MTVA |
Indexes, lists and sector
MetaVia stock FAQ
What is MetaVia's stock price today?
MTVA last traded at $1.46 as of Oct 7, 4:00 PM EDT, down 1.35% on the day. Prices are delayed at least 15 minutes.
When is MetaVia's next earnings date?
MetaVia is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.94.
What is the MTVA 52-week high?
The 52-week high for MTVA is $14.85 and the 52-week low is $0.966. The stock is currently 90.2% below its high.